Hybrid-model imaging systems combining fluorescence and ultrasound were presented alongside Baoqiang Li of the Institute of Biomedical Engineering of École Polytechnique de Montréal. Nüvü Camēras highlighted various technological advances happening across the province and showcased at the Quebec booth.
Uniting a wide variety of trade shows including Laser Expo, Lens Expo, Vision Japan, IR+UV Expo, Positioning Expo as well as Mebios Japan, this event gave an ideal opportunity to discover the very latest in modern optics, photonics and imaging technology. Nüvü Camēras was there to meet and discuss new applications for its EMCCD technology.
Single-molecule imaging results were presented alongside Dr. Paul Maddox of the Institute for Research in Immunology and Cancer. Nüvü Camēras’ EM N2, an innovative and highly sensitive EMCCD camera, was used to observe specific behaviours of cancerous cells.
A presentation intended to illustrate the various advantages of EMCCD technology with a focus on photon counting capabilities was given at the 2011 CCA’s Cytometry and Microscopy Symposium in Toronto entitled “EMCCD Cameras: New Developments and Applications”.
The EM N2’s various applications, advantages and benefits in the field of biomedical research were presented at the National Optics Institute.
The Canadian Space Commerce Association presented Nüvü Camēras’ technology to the ISU’s Space Studies Program as one of the most promising Canadian technologies for applications in astronomy.
Several workshops were held to promote the applications, advantages and benefits of the EM N2 in biomedical research.
The EM N2’s various applications, advantages and benefits in the field of biomedical research were demonstrated at the McGill University Life Sciences Imaging Facility.
The EM N2’s various applications, advantages and benefits in the field of biomedical research were demonstrated across several health research institutes.
